We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
668 14 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Neptune Wellness Solutions researches, develops and commercializes proprietary bioactive
ingredients and products with the goal of superior added-value and clinically proven health benefits. The
Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from
abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune’s
first commercially available product is Neptune Krill Oil (NKO®), which represents marine based omega-3
phospholipids with potential in cardiovascular, cognitive and anti-inflammatory disorders. Neptune is pursuing
market opportunities in the nutraceutical market including dietary supplements and functional foods. The
Company is also pursuing opportunities in the pharmaceutical market through its pharmaceutical subsidiaries,Acasti and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications).

NOTE: Neptune trades on Toronto.. For Canadian & US quote, enter NEPT

Acasti Pharma Inc. is 35% owned by Neptune.. For Canadian & US quote, enter ACST
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
668Acasti sits pretty as raise brings $400M for Amarin bioworld.comSultan1last Friday
667Form 13G for ACST Schedule filed to report acquisition of beneficial ownershipSultan-last Friday
666Neptune Wellness Solutions Closes US$41 Million Private Placement finance.yahooSultan-last Thursday
665Oppenheimer initiated Acasti Pharma (ACST) coverage with Outperform rating and pSultan-last Thursday
664Insider Trades Pretty rich payout to new CEO.. 2,800,000 restricted share unSultan-last Monday
663Introducing The New NYSE Pure-Play Cannabis ETF thecannabisinvestor.caSultan-July 13
662Two prominent research firms initiate coverage on Acasti Pharma with Buy rating Sultan-July 13
661Aegis Capital analyst Nathan Weinstein initiates coverage on Acasti Pharma (NASDSultan-July 9
660Neptune Appoints Schmidt’s Naturals Co-Founder Michael Cammarata CEO As CPG ExecSultan-July 9
659Neptune Appoints Michael Cammarata as Chief Executive Officer 8
658Acasti Pharma, Inc. (ACST) CEO Jan D'Alvise on Q4 2019 Results - Earnings CaSultan-June 26
657Acasti Pharma Provides Fiscal 2019 Year-End Business Update acastipharma.comSultan-June 26
656Home-Run Hitters, At Bat With Acasti Pharma seekingalpha.comSultan1June 25
655 Neptune Wellness Solutions Inc forms bullish "Continuation Diamond" cSultan1June 25
654Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering Sultan1June 24 [graphic]Sultan1June 21
652The Green Organic Dutchman inks pact with Neptune to make organic wellness produSultan2June 20
651Success of Amarin trial could jumpstart further omega 3s research, expert says18Sultan1June 20
650Jackie Khayat; When building a new industry you need to make bold decisions and Sultan1June 19
649These 2 Under-the-Radar Pot Stocks Just Signed the Largest Extraction Deal to DaSultan-June 18
648Neptune Receives Health Canada's Amendments to Expand Capacity to 200,000 kgSultan1June 17
647Neptune Wellness is a buy, says GMP Securities cantechletter.comSultan1June 17
646GMP Research Report 13
645CC Presentation neptunecorp.comSultan1June 13
644Neptune Wellness Solutions Inc. (NEPT) CEO Jim Hamilton on Q4 2019 Results - EarSultan1June 12
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):